Contact Us


Adopting Biosimilars in Oncology Practice: A Panel Discussion

Watch expert speakers discuss the barriers to adopting new biosimilar products, best practices for implementation of new biosimilars within different practice settings, and updates on legislative initiatives.

Play Video


Ali Ahmed (Moderator)
Senior Vice President, Biosimilars
Fresenius Kabi USA

Sophia Humphreys, PharmD, MHA
System Director, Formulary Management and
Clinical Programs
Sutter Health, Sacramento, CA

David Waterhouse, MD, MPH
Associate Medical Director DFCI Network Host Hospital/Systems Relations Milford, MA

Craig Burton, MBA
Executive Director, Biosimilars Council
Senior Vice President, Policy and Strategic Alliances
Association for Accessible Medicines
Washington, DC

We want to hear from you!

Have biosimilars made an impact on your patients and practice? To share your story, please visit Your story could make an impact on increasing awareness of patient access to important biologic treatments. Learn more.

Advanced science, manufacturing and support for biosimilars